España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Rhythm Pharmaceuticals
RYTM
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$57.55
0.00
0.00%
After Hours: Feb 18, 4:00 PM EDT
Get Report
Comment
Q4 2024 Earnings in 7 days from now on Wed Feb 26th, before the market open
Conference call scheduled in 7 days at 8:00 AM
Click to view the webcast
Rhythm Pharmaceuticals (RYTM) Forecast
News
Earnings
Rhythm Pharmaceuticals (RYTM) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock
Rhythm Pharmaceuticals Stock (NASDAQ: RYTM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, February 19, 2025
7 Analysts Assess Rhythm Pharmaceuticals: What You Need To Know
Benzinga Insights
Needham Reiterates Buy on Rhythm Pharmaceutic...
Benzinga Newsdesk
Friday, January 10, 2025
Rhythm Reports Preliminary Unaudited Net Reve...
Benzinga Newsdesk
Monday, December 23, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Rhythm ...
Benzinga Newsdesk
Friday, December 20, 2024
Rhythm Pharmaceuticals' Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential
Vandana Singh
hythm Pharmaceuticals Secures FDA Approval Fo...
Benzinga Newsdesk
Forecasting The Future: 14 Analyst Projections For Rhythm Pharmaceuticals
Benzinga Insights
Oppenheimer Initiates Coverage On Rhythm Phar...
Benzinga Newsdesk
Thursday, December 05, 2024
Goldman Sachs Maintains Buy on Rhythm Pharmac...
Benzinga Newsdesk
Wednesday, December 04, 2024
HC Wainwright & Co. Reiterates Buy on Rhythm ...
Benzinga Newsdesk
Tuesday, December 03, 2024
Rhythm Pharma's IMCIVREE (Setmelanotide) Bags...
Benzinga Newsdesk
Monday, November 25, 2024
A Glimpse Into The Expert Outlook On Rhythm Pharmaceuticals Through 13 Analysts
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Rhythm ...
Benzinga Newsdesk
Tuesday, November 19, 2024
Canaccord Genuity Maintains Buy on Rhythm Pha...
Benzinga Newsdesk
Thursday, November 14, 2024
Reported Earlier, Rhythm Pharmaceuticals Publ...
Benzinga Newsdesk
Thursday, November 07, 2024
HC Wainwright & Co. Maintains Buy on Rhythm P...
Benzinga Newsdesk
Wednesday, November 06, 2024
Rhythm Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Canaccord Genuity Maintains Buy on Rhythm Pha...
Benzinga Newsdesk
TD Cowen Maintains Buy on Rhythm Pharmaceutic...
Benzinga Newsdesk
Needham Maintains Buy on Rhythm Pharmaceutica...
Benzinga Newsdesk
Tuesday, November 05, 2024
Rhythm Pharmaceuticals Q3 2024 GAAP EPS $(0.7...
Benzinga Newsdesk
Monday, November 04, 2024
What's Next: Rhythm Pharmaceuticals's Earnings Preview
Benzinga Insights
Wednesday, October 30, 2024
Needham Reiterates Buy on Rhythm Pharmaceutic...
Benzinga Newsdesk
Friday, October 25, 2024
Critical Insights From Rhythm Pharmaceuticals Analyst Ratings: What You Need To Know
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Rhythm ...
Benzinga Newsdesk
Thursday, October 24, 2024
Rhythm Pharmaceuticals, Axovia Therapeutics P...
Benzinga Newsdesk
Monday, October 21, 2024
Guggenheim Initiates Coverage On Rhythm Pharm...
Benzinga Newsdesk
Monday, October 14, 2024
B of A Securities Maintains Neutral on Rhythm...
Benzinga Newsdesk
Monday, October 07, 2024
Navigating 5 Analyst Ratings For Rhythm Pharmaceuticals
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Rhythm ...
Benzinga Newsdesk
Wednesday, September 18, 2024
What 4 Analyst Ratings Have To Say About Rhythm Pharmaceuticals
Benzinga Insights
HC Wainwright & Co. Initiates Coverage On Rhy...
Benzinga Newsdesk
Tuesday, September 17, 2024
Rhythm Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
JMP Securities Initiates Coverage On Rhythm P...
Benzinga Newsdesk
Monday, August 26, 2024
Rhythm Pharmaceutical shares are trading high...
Benzinga Newsdesk
Rhythm Pharmaceuticals Announces FDA Acceptan...
Benzinga Newsdesk
Wednesday, August 07, 2024
Needham Reiterates Buy on Rhythm Pharmaceutic...
Benzinga Newsdesk
Tuesday, August 06, 2024
Rhythm Pharmaceuticals Says Cash On-hand Expe...
Benzinga Newsdesk
Rhythm Pharmaceuticals Q2 2024 GAAP EPS $(0.5...
Benzinga Newsdesk
Wednesday, July 31, 2024
Rhythm Pharmaceuticals Announces European Com...
Benzinga Newsdesk
Thursday, July 25, 2024
A Glimpse Into The Expert Outlook On Rhythm Pharmaceuticals Through 4 Analysts
Benzinga Insights
Needham Maintains Buy on Rhythm Pharmaceutica...
Benzinga Newsdesk
Tuesday, July 23, 2024
Rhythm Pharmaceuticals First Patients Dosed I...
Benzinga Newsdesk
Friday, June 28, 2024
Rhythm Says European Medicines Agency's CHMP ...
Benzinga Newsdesk
Tuesday, June 11, 2024
Rhythm Pharmaceuticals Grants Inducement Equi...
Benzinga Newsdesk
Monday, June 03, 2024
Rhythm Pharmaceuticals Presents First Patient...
Benzinga Newsdesk
Wednesday, May 22, 2024
Rhythm Pharmaceuticals Announced That The Nat...
Benzinga Newsdesk
Wednesday, May 08, 2024
Canaccord Genuity Maintains Buy on Rhythm Pha...
Benzinga Newsdesk
B of A Securities Downgrades Rhythm Pharmaceu...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
